Robert J. Friedman

5.5k total citations
81 papers, 3.1k citations indexed

About

Robert J. Friedman is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Robert J. Friedman has authored 81 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 22 papers in Molecular Biology and 18 papers in Epidemiology. Recurrent topics in Robert J. Friedman's work include Cutaneous Melanoma Detection and Management (44 papers), Melanoma and MAPK Pathways (16 papers) and Nonmelanoma Skin Cancer Studies (11 papers). Robert J. Friedman is often cited by papers focused on Cutaneous Melanoma Detection and Management (44 papers), Melanoma and MAPK Pathways (16 papers) and Nonmelanoma Skin Cancer Studies (11 papers). Robert J. Friedman collaborates with scholars based in United States, Canada and Sweden. Robert J. Friedman's co-authors include Darrell S. Rigel, Alfred W. Kopf, Alfred W. Kopf, Edward Heilman, Robert S. Bart, Marcia Levenstein, David Polsky, Naheed R. Abbasi, Iman Osman and Helen M. Shaw and has published in prestigious journals such as JAMA, Circulation Research and Neurology.

In The Last Decade

Robert J. Friedman

79 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert J. Friedman United States 30 2.3k 940 901 764 287 81 3.1k
Ulf Ellwanger Germany 22 1.9k 0.8× 373 0.4× 450 0.5× 855 1.1× 112 0.4× 30 2.3k
Andreas Blum Germany 30 2.1k 0.9× 986 1.0× 1.1k 1.2× 339 0.4× 497 1.7× 112 2.8k
Christopher K. Bichakjian United States 30 3.4k 1.4× 561 0.6× 914 1.0× 1.1k 1.5× 79 0.3× 61 4.7k
Pietro Rubegni Italy 29 1.9k 0.8× 1.2k 1.3× 937 1.0× 358 0.5× 302 1.1× 254 3.5k
Helmut Breuninger Germany 37 2.9k 1.2× 2.3k 2.4× 2.8k 3.1× 756 1.0× 75 0.3× 230 5.2k
Holger A. Haenssle Germany 24 1.3k 0.5× 604 0.6× 628 0.7× 348 0.5× 400 1.4× 134 2.3k
Brendon J. Coventry Australia 27 3.8k 1.6× 548 0.6× 1.4k 1.6× 1.3k 1.7× 254 0.9× 98 5.1k
Kee Yang Chung South Korea 31 874 0.4× 1.3k 1.3× 665 0.7× 899 1.2× 100 0.3× 211 3.5k
R. J. Friedman United States 12 887 0.4× 300 0.3× 298 0.3× 264 0.3× 210 0.7× 22 1.8k
Eduardo Nagore Spain 34 2.9k 1.2× 1.9k 2.0× 1.4k 1.6× 2.1k 2.7× 50 0.2× 301 6.0k

Countries citing papers authored by Robert J. Friedman

Since Specialization
Citations

This map shows the geographic impact of Robert J. Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Friedman more than expected).

Fields of papers citing papers by Robert J. Friedman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Friedman. The network helps show where Robert J. Friedman may publish in the future.

Co-authorship network of co-authors of Robert J. Friedman

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Friedman. A scholar is included among the top collaborators of Robert J. Friedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Friedman. Robert J. Friedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schram, Alison M., Abdul Rafeh Naqash, Eric B. Haura, et al.. (2025). The Bi-steric, mTORC1-Selective Inhibitor, RMC-5552, in Advanced Solid Tumors: A Phase 1 Trial. Clinical Cancer Research. 31(23). 4933–4943.
2.
Catenacci, Matthew J., et al.. (2021). Effect of fly ash composition and component quantities on the gamma radiation shielding properties of geopolymer. Progress in Nuclear Energy. 140. 103889–103889. 15 indexed citations
3.
Friedman, Robert J.. (2010). Religious Discrimination in the Workplace: The Persistent Polarized Struggle. eYLS (Yale Law School). 11(2). 143.
4.
Friedman, Robert J.. (2010). Take Two of These and Sue Me in the Morning: Efficacy of the Learned Intermediary Doctrine in Prescription Drug Failure to Warn Cases. eYLS (Yale Law School). 22(2). 278. 2 indexed citations
5.
Abbasi, Naheed R., Molly Yancovitz, Dina Gutkowicz–Krusin, et al.. (2008). Utility of Lesion Diameter in the Clinical Diagnosis of Cutaneous Melanoma. Archives of Dermatology. 144(4). 469–74. 42 indexed citations
6.
7.
Abbasi, Naheed R., Helen M. Shaw, Darrell S. Rigel, et al.. (2004). Early Diagnosis of Cutaneous Melanoma. JAMA. 292(22). 2771–2771. 407 indexed citations
8.
Friedman, Robert J., et al.. (2003). Treating Pain Patients at Risk: Evaluation of a Screening Tool in Opioid-Treated Pain Patients With and Without Addiction. Pain Medicine. 4(2). 182–185. 60 indexed citations
9.
Friedman, Robert J., et al.. (2003). Severe intraoperative hypertension and opioid-resistant postoperative pain in a methadone-treated patient. Journal of Pain. 4(5). 289–290. 3 indexed citations
10.
Friedman, Robert J. & Edward Heilman. (2002). The pathology of malignant melanoma. Dermatologic Clinics. 20(4). 659–676. 21 indexed citations
11.
Friedman, Robert J., et al.. (2000). Oral Ketamine in Hepatocellular Carcinoma. Pain Medicine. 1(2). 181–182. 2 indexed citations
12.
Rigel, Darrell S., Robert J. Friedman, & Alfred W. Kopf. (1996). The incidence of malignant melanoma in the United States: Issues as we approach the 21st century. Journal of the American Academy of Dermatology. 34(5). 839–847. 270 indexed citations
13.
Salopek, Thomas G., Johnny Slade, Ashfaq A. Marghoob, et al.. (1995). Management of cutaneous malignant melanoma by dermatologists of the American Academy of Dermatology. II. Definitive surgery for malignant melanoma. Journal of the American Academy of Dermatology. 33(3). 451–461. 20 indexed citations
14.
Grant‐Kels, Jane M., A. Bernard Ackerman, David E. Elder, et al.. (1991). The Histopathology of Dysplastic Nevi. American Journal of Dermatopathology. 13(1). 38–51. 29 indexed citations
15.
Friedman, Robert J., et al.. (1990). Atypical mole syndrome. Journal of the American Academy of Dermatology. 22(1). 117–118. 43 indexed citations
16.
Rivers, Jason K., Alfred W. Kopf, Darrell S. Rigel, et al.. (1990). Clinical characteristics of malignant melanomas developing in persons with dysplastic nevi. Cancer. 65(5). 1232–1236. 51 indexed citations
17.
Olson, Jeffrey J., et al.. (1990). Cerebral radioprotection by pentobarbital: dose-response characteristics and association with GABA agonist activity. Journal of neurosurgery. 72(5). 749–758. 24 indexed citations
18.
Kopf, Alfred W., Jason K. Rivers, Marcia Levenstein, et al.. (1988). Skin Types in Dysplastic Nevus Syndrome. The Journal of Dermatologic Surgery and Oncology. 14(8). 827–831. 13 indexed citations
19.
Rigel, Darrell S., Alfred W. Kopf, & Robert J. Friedman. (1987). The rate of malignant melanoma in the United States: Are we making an impact?. Journal of the American Academy of Dermatology. 17(6). 1050–1053. 108 indexed citations
20.
Trau, Henri, Darrell S. Rigel, Matthew N. Harris, et al.. (1983). Metastases of thin melanomas. Cancer. 51(3). 553–556. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ulf Ellwanger Breakdown of academic impact, for papers by Andreas Blum Breakdown of academic impact, for papers by Christopher K. Bichakjian Breakdown of academic impact, for papers by Pietro Rubegni Breakdown of academic impact, for papers by Helmut Breuninger Breakdown of academic impact, for papers by Holger A. Haenssle Breakdown of academic impact, for papers by Brendon J. Coventry Breakdown of academic impact, for papers by Kee Yang Chung Breakdown of academic impact, for papers by R. J. Friedman Breakdown of academic impact, for papers by Eduardo Nagore
Rankless by CCL
2026